Researched and written by Keith Bishop, Integrative Cancer Educator, Clinical Nutritionist, Cancer Coach, and Retired Pharmacist
Melatonin, often called the "sleep hormone," is a naturally occurring compound produced by the pineal gland in the brain. While its primary role is to regulate the sleep-wake cycle, emerging research has revealed its potential as a potent anticancer agent. This blog explores melatonin's anticancer properties, additional health benefits, potential side effects, role in cancer treatment, recommended dosages, and possible drug interactions.
Melatonin is a hormone that helps regulate circadian rhythms, ensuring a healthy sleep-wake cycle. It is also a potent antioxidant, capable of neutralizing free radicals and reducing oxidative stress, which are key contributors to cellular damage and aging.
Research has shown that melatonin exhibits several anticancer properties:

Learn How to Select a Quality Dietary Supplement
Melatonin has demonstrated anticancer activity against various types of cancers across in vitro, in vivo, animal, and human studies. Here's a list of cancers where melatonin's effects have been studied:
Click here to download and view the seminar handout for Melatonin for Brain and Cancer.
Beyond its anticancer properties, melatonin offers several additional health benefits:
While melatonin is generally safe, some users may experience mild side effects, including:
Melatonin may rarely cause vivid dreams or interact with certain medications, which underscores the importance of consulting a healthcare provider before use.
A new preliminary study presented at the American Heart Association’s Scientific Sessions 2025 has raised eyebrows in the medical community. Researchers analyzed health records from over 130,000 adults with chronic insomnia and found that those who used melatonin for more than a year had a 90% higher risk of developing heart failure, were 3.5 times more likely to be hospitalized, and faced nearly double the risk of death from any cause compared to non-users. While the studies do not establish causation, and many experts urge caution in interpreting the results, they highlight the need for more rigorous trials to assess melatonin’s long-term safety profile
But before you panic or toss your melatonin supplements—here’s the nuance.
Necessary Clarification: This research is preliminary. It has not yet been peer-reviewed or published in a medical journal, which means it hasn’t undergone the rigorous scrutiny required to confirm its findings. Many studies presented at conferences never make it to publication. Factors such as insomnia severity, psychiatric conditions, or other medications may be influencing the results.
Melatonin has shown promising cardiovascular benefits in several peer-reviewed studies, suggesting its potential role beyond sleep regulation. Experimental and clinical research indicates that melatonin may reduce oxidative stress and inflammation in cardiac tissue, thereby reducing myocardial damage during ischemic events (Dominguez-Rodriguez et al., J Pineal Res. 2006;40(2):135–139). In hypertensive patients, melatonin supplementation has been associated with lower nighttime blood pressure and improved circadian rhythm of blood pressure (Scheer et al., Hypertension. 2004;43(2):192–197). Moreover, its neuroprotective and vasodilatory effects may contribute to a reduced risk of stroke in animal models and small human trials (Reiter et al., J Pineal Res. 2005;39(3):223–226). Longitudinal data also suggest that melatonin’s antioxidant properties may support healthy aging and longevity, particularly in populations with disrupted circadian rhythms (Hardeland et al., Ageing Res Rev. 2012;11(2):164–170). While these findings are encouraging, they stem from controlled settings and short-term interventions—highlighting the need for long-term, large-scale human trials to confirm melatonin’s protective effects in real-world populations.
Stay Informed: I’ll be following this story closely. I'll continue to update this blog as information develops. Subscribing to my email newsletter is the best way to stay informed about when I update my blog posts.
Clinical studies have explored a wide range of dosages, typically between 10 mg and 20 mg per day, administered alongside conventional cancer therapies. Higher doses, up to 200 mg, have also been studied, showing promising results with minimal side effects.
Melatonin may interact with certain medications, including:
It is crucial to discuss melatonin use with a healthcare provider to avoid adverse interactions.
Melatonin is a versatile and promising compound with significant anticancer potential. Its ability to enhance conventional cancer treatments and its antioxidant and immune-boosting properties make it a valuable addition to the fight against cancer. However, as with any supplement, it is essential to consult a healthcare professional before use.
Melatonin at Fullscript Discount is automatically applied.
As a dedicated cancer coach, I provide personalized guidance and unwavering support to empower individuals navigating their cancer journey. My approach focuses on holistic well-being, blending evidence-based practices with compassionate care to address the physical, emotional, and mental challenges of cancer. https://www.prevailovercancer.com/coaching
Whether you seek strategies to manage treatments, improve quality of life, or explore complementary therapies, my coaching is tailored to your unique needs and goals. Together, we’ll chart a path toward resilience, hope, and healing. Together – We Prevail Over Cancer!™